AbbVie (ABBV) Leases (2019 - 2024)
Historic Leases for AbbVie (ABBV) over the last 6 years, with Q4 2024 value amounting to $723.0 million.
- AbbVie's Leases fell 282.26% to $723.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $723.0 million, marking a year-over-year decrease of 282.26%. This contributed to the annual value of $723.0 million for FY2024, which is 282.26% down from last year.
- According to the latest figures from Q4 2024, AbbVie's Leases is $723.0 million, which was down 282.26% from $744.0 million recorded in Q4 2023.
- AbbVie's 5-year Leases high stood at $895.0 million for Q4 2020, and its period low was $723.0 million during Q4 2024.
- In the last 5 years, AbbVie's Leases had a median value of $744.0 million in 2023 and averaged $772.2 million.
- Per our database at Business Quant, AbbVie's Leases skyrocketed by 16017.44% in 2020 and then crashed by 1486.03% in 2021.
- Over the past 5 years, AbbVie's Leases (Quarter) stood at $895.0 million in 2020, then fell by 14.86% to $762.0 million in 2021, then dropped by 3.28% to $737.0 million in 2022, then grew by 0.95% to $744.0 million in 2023, then dropped by 2.82% to $723.0 million in 2024.
- Its last three reported values are $723.0 million in Q4 2024, $744.0 million for Q4 2023, and $737.0 million during Q4 2022.